Sale!

SCN2A Gene Dravet Syndrome Genetic Test

4,400 د.إ

-21%

The SCN2A Gene Dravet Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SCN2A gene, which have been linked to Dravet Syndrome. Dravet Syndrome is a severe form of epilepsy that emerges in the first year of life, characterized by frequent, prolonged seizures often triggered by high temperatures or fever. Beyond seizures, individuals with Dravet Syndrome may also experience developmental delays, speech and walking issues, sleep disturbances, and other health complications.

The SCN2A gene plays a crucial role in the function of brain cells by coding for a protein that is essential for the proper transmission of electrical signals in the nervous system. Mutations in this gene can disrupt these signals, leading to the symptoms observed in Dravet Syndrome. Identifying mutations in the SCN2A gene can confirm a diagnosis of Dravet Syndrome, allowing for tailored treatment plans that can significantly improve the quality of life for affected individuals.

The test offered by DNA Labs UAE involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in their state-of-the-art facilities. The cost of the test is 4400 AED, which reflects the sophisticated technology and expertise required to accurately identify mutations in the SCN2A gene.

By opting for the SCN2A Gene Dravet Syndrome Genetic Test, families and individuals gain access to crucial information that can guide clinical decisions, from medication choices to lifestyle adjustments, ultimately leading to better management of Dravet Syndrome.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SCN2A Gene Dravet Syndrome Genetic Test

Introduction

The SCN2A gene is one of the genes associated with Dravet syndrome, a rare form of epilepsy that usually begins in infancy or early childhood. Dravet syndrome is characterized by seizures that are often difficult to control with medication, developmental delays, and other neurological symptoms.

Test Components

  • Test Name: SCN2A Gene Dravet Syndrome Genetic Test
  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to the SCN2A Gene Dravet Syndrome Genetic Test, it is important to gather the clinical history of the patient who is going for the test. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with SCN2A Gene Dravet Syndrome.

Test Details

NGS (next-generation sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once. This type of testing can be used to identify mutations or changes in the SCN2A gene that may be associated with Dravet syndrome.

NGS genetic testing for Dravet syndrome may be recommended for individuals who have symptoms of the condition or for family members of individuals with a known SCN2A mutation. The test may also be used for prenatal diagnosis in families with a history of Dravet syndrome.

It is important to note that genetic testing for Dravet syndrome is not always conclusive, and a negative test result does not rule out the possibility of the condition. A diagnosis of Dravet syndrome is typically based on a combination of clinical symptoms, family history, and genetic testing results.

Test Name SCN2A Gene Dravet syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SCN2A Gene Dravet syndrome NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with SCN2A Gene Dravet syndrome
Test Details

The SCN2A gene is one of the genes associated with Dravet syndrome, a rare form of epilepsy that usually begins in infancy or early childhood. Dravet syndrome is characterized by seizures that are often difficult to control with medication, developmental delays, and other neurological symptoms.

NGS (next-generation sequencing) genetic testing is a type of genetic testing that uses advanced technology to analyze multiple genes at once. This type of testing can be used to identify mutations or changes in the SCN2A gene that may be associated with Dravet syndrome.

NGS genetic testing for Dravet syndrome may be recommended for individuals who have symptoms of the condition, or for family members of individuals with a known SCN2A mutation. The test may also be used for prenatal diagnosis in families with a history of Dravet syndrome.

It is important to note that genetic testing for Dravet syndrome is not always conclusive, and a negative test result does not rule out the possibility of the condition. A diagnosis of Dravet syndrome is typically based on a combination of clinical symptoms, family history, and genetic testing results.